Davita-Los Angeles Dialysis Center is a medicare approved dialysis facility center in Los Angeles, California and it has 28 dialysis stations. It is located in Los Angeles county at 3901 S. Western Avenue, Los Angeles, CA, 90062. You can reach out to the office of Davita-Los Angeles Dialysis Center at (323) 294-0670. This dialysis clinic is managed and/or owned by Davita. Davita-Los Angeles Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 1990. The medicare id for this facility is 052695 and it accepts patients under medicare ESRD program.
| Name | Davita-Los Angeles Dialysis Center |
|---|---|
| Location | 3901 S. Western Avenue, Los Angeles, California |
| No. of Dialysis Stations | 28 |
| Medicare ID | 052695 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 3901 S. Western Avenue, Los Angeles, California, 90062 | |
| (323) 294-0670 | |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| NPI Number | 1558320366 |
| Organization Name | Los Angeles Dialysis Center |
| Doing Business As | Los Angeles Dialysis Center |
| Address | 3901 S Western Ave Los Angeles, California, 90062 |
| Phone Number | (323) 294-1310 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| NPI Number | 1841547460 |
| Organization Name | Los Angeles Dialysis Center |
| Doing Business As | Glassland Dialysis Llc |
| Address | 3901 S Western Ave Los Angeles, California, 90062 |
| Phone Number | (323) 294-0670 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 61% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 17% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 22% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 54% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 14% |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 61% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 18% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 21% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 58% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 32% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 12% |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 80% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 20% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 12% |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 74 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 175 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1611 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 116 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 86 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Los Angeles Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 195 |
| Hypercalcemia patient months | 1835 |
| Patients with Serumphosphor | 197 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 110 |
| Patient months included in arterial venous fistula and catheter summaries | 866 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 125 |
| Hospitalization Rate in facility | 183 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 300.9 |
| Hospitalization Rate: Lower Confidence Limit | 120 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita-Los Angeles Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 27.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 38.6 |
| Readmission Rate: Lower Confidence Limit | 18.8 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita-Los Angeles Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .64 (As Expected) |
| SIR: Upper Confidence Limit | 1.21 |
| SIR: Lower Confidence Limit | .3 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita-Los Angeles Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 110 |
| Transfusion Rate in facility | 43.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 87.4 |
| Transfusion Rate: Lower Confidence Limit | 23.8 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita-Los Angeles Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 727 |
| Mortality Rate in facility | 18 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.8 |
| Mortality Rate: Lower Confidence Limit | 13.9 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago
Kaiser Foundation Hospital Medical Ctr.- Sunset Location: Dialysis Unit 4700 Sunset Blvd., 2nd Floor, Los Angeles, California, 90027 Phone: (323) 783-5580 |
Kaiser Foundation Hospital Medical Ctr.- West Los Angeles Location: Dialysis Unit 6041 Cadillac Avenue, Suite 442, Los Angeles, California, 90034 Phone: (323) 857-3245 |
ST. Vincent Dialysis Center, Inc. Location: 201 S. Alvarado Street, Suite 220, Los Angeles, California, 90057 Phone: (213) 484-7425 |
Fmc-Rai-Compton-Los Angeles Location: 11859 Compton Avenue, Los Angeles, California, 90059 Phone: (323) 563-1140 |
Davita-East La Plaza Dialysis Location: 1700 Cesar E. Chavez Ave., Suite L-100, Los Angeles, California, 90033 Phone: (323) 261-0484 |
News Archive
For the nation's fastest growing population, cancer ranked as the number one leading cause of death among Hispanics, based on a 2012 American Cancer Society report.
Hanger Orthopedic Group, Inc. is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.
Scientists at the University of Liverpool have shown how the travel and socialisation patterns of people in Southern China can give greater insight into how new diseases such as bird flu may spread between populations.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.
› Verified 6 days ago